FDA Peptide Reclassification 2026: What Researchers Want FDA Peptide Regulation and HHS Policy Holt Law The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting FDA considers adding a dozen peptides to its bulk drug compounding list RAPS HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax